Kappa Bioscience is a Norway-based company that produces vitamin K2 MK-7 ingredient under the brand name K2VITAL®. One of the company's core assets is the patent covering the synthesis of pure vitamin K2 as menaquinone-7. Kappa provides global markets with a portfolio of all-trans K2 MK-7 ingredient solutions, including microencapsulated DELTA for stability in mineral formulations. The company invests heavily in R&D innovation, market education and commercial strategies for the rapid launch of consumer products.
| Website | http://www.kappabio.com |
| Revenue | $6.6 million |
| Employees | View employees |
| Founded | 2006 |
| Address | Bldg B 2 Silurveien, Oslo, Oslo 0380, NO |
| Phone | +1 949-419-0288 |
| Industry | Manufacturing General, Biotechnology, Manufacturing, Pharmaceuticals |
| Competitors | BASF, ADM, DSM, Lonza, Glanbia Nutritionals, Natrol, Inc., Nutraceutical Products Co, Kerry Ingredients, NutraScience Labs, Chemi Nutra +39 more (view full list) |
| SIC | SIC Code 28 Companies, SIC Code 283 Companies |
| NAICS | NAICS Code 32 Companies, NAICS Code 3254 Companies, NAICS Code 32541 Companies, NAICS Code 325 Companies |
Looking for a particular Kappa Bioscience employee's phone or email?
Kappa Bioscience Questions
The Kappa Bioscience annual revenue was $6.6 million in 2026.
Kappa Bioscience is based in Oslo, Oslo.
The NAICS codes for Kappa Bioscience are [32, 3254, 32541, 325].
The SIC codes for Kappa Bioscience are [28, 283].
